Opioids And The Limits Of US FDA's Authority
This article was originally published in SRA
The US Food and Drug Administration will require that patients receive a medication guide when prescribed immediate-release opioids. The move may be a precursor to adding the products to the existing Risk Evaluation and Mitigation Strategy (REMS) for the extended-release version of the pain products.
Register for our free email digests: